Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy

Journal of Urology

Volumn 174, Issue 2, 2005, Pages 500-504

  Eggener, Scott E ^a   Roehl, Kimberly A ^b   Catalona, William J ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Urology ^*  (United States)

Author keywords

Biopsy; Mass screening; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 22144474404     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000165203.40973.0f     Document Type: Article

References (17)

1. Roehl, K. A., Antenor, J. A. V. and Catalona, W. J.: Serial biopsy results in prostate cancer screening study. J Urol, 167: 2435, 2002
2. Han, M., Partin, A. W., Zahurak, M., Piantadosi, S., Epstein, J. I. and Walsh, P. C.: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol, 169: 517, 2003
3. Zackrisson, B., Aus, G., Lilja, H., Lodding, P., Pihl, C. G. and Hugosson, J.: Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Eur Urol, 43: 327, 2003
4. Roehl, K. A., Antenor, J. A. V. and Catalona, W. J.: Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. range. J Urol, 168: 922, 2002
5. Lopez-Corona, E., Ohori, M., Scardino, P. T., Reuter, V. E., Gonen, M. and Kattan, M. W.: A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol, 170: 1184, 2003
6. Djavan, B., Zlotta, A., Remzi, M., Ghawidel, K., Basharkhah, A., Schulman, C. C. et al: Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol, 163: 1144, 2000
7. O'dowd, G., J., Miller, M. C., Orozco, R. and Veltri, R. W.: Analysis of repeated biopsy results within 1 year after a non-cancer diagnosis. Urology, 55: 553, 2000
8. Fowler, J. E., Jr., Bigler, S. A., Miles, D. and Yalkut, D. A.: Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol, 163: 813, 2000
9. Keetch, D. W., McMurtry, J. M., Smith, D. S., Andriole, G. L. and Catalona, W. J.: Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol, 156:428, 1996
10. Catalona, W. J., Smith, D. S. and Ornstein, D. K.: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA, 277: 1452, 1997
11. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. et al: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA, 274: 1214, 1995
12. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270: 948, 1993
13. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324: 1156, 1991
14. Mian, B. M., Naya, Y., Okihara, K., Vakar-Lopez, F., Troncoso, P. and Babaian, R. J.: Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology, 60: 836, 2002
15. Durkan, G. C. and Greene, D. R.: Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? BJU Int, 83: 34, 1999
16. Perrotti, M., Han, K.-R., Epstein, R. E., Kennedy, E. C., Rabbani, F., Badani, K. et al: Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol, 162: 1314, 1999
17. Horinaga, M., Nakashima, J., Ishibashi, M., Oya, M., Ohigashi, T., Marumo, K. et al: Clinical value of prostate specific antigen based parameters for the detection of prostate cancer on repeat biopsy: the usefulness of complexed prostate specific antigen adjusted for transition zone volume. J Urol, 168: 986, 2002